These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36889133)

  • 1. Probing the interactions between amyloidogenic proteins and bio-membranes.
    Ma L; Li X; Petersen RB; Peng A; Huang K
    Biophys Chem; 2023 May; 296():106984. PubMed ID: 36889133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misfolding of amyloidogenic proteins and their interactions with membranes.
    Relini A; Marano N; Gliozzi A
    Biomolecules; 2013 Dec; 4(1):20-55. PubMed ID: 24970204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second Sphere Interactions in Amyloidogenic Diseases.
    Roy M; Nath AK; Pal I; Dey SG
    Chem Rev; 2022 Jul; 122(14):12132-12206. PubMed ID: 35471949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.
    Cheng B; Gong H; Xiao H; Petersen RB; Zheng L; Huang K
    Biochim Biophys Acta; 2013 Oct; 1830(10):4860-71. PubMed ID: 23820032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-polyphenolic natural inhibitors of amyloid aggregation.
    Ma L; Yang C; Zheng J; Chen Y; Xiao Y; Huang K
    Eur J Med Chem; 2020 Apr; 192():112197. PubMed ID: 32172082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between amyloidogenic proteins and biomembranes in protein misfolding diseases: Mechanisms, contributors, and therapy.
    Cheng B; Li Y; Ma L; Wang Z; Petersen RB; Zheng L; Chen Y; Huang K
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1876-1888. PubMed ID: 29466701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
    Marrero-Winkens C; Sankaran C; Schätzl HM
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
    Huang L; Liu X; Cheng B; Huang K
    Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.
    Brender JR; Salamekh S; Ramamoorthy A
    Acc Chem Res; 2012 Mar; 45(3):454-62. PubMed ID: 21942864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundamentals of cross-seeding of amyloid proteins: an introduction.
    Ren B; Zhang Y; Zhang M; Liu Y; Zhang D; Gong X; Feng Z; Tang J; Chang Y; Zheng J
    J Mater Chem B; 2019 Dec; 7(46):7267-7282. PubMed ID: 31647489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the interplay between amyloidogenic proteins and membranes using lipid monolayers and bilayers.
    Relini A; Marano N; Gliozzi A
    Adv Colloid Interface Sci; 2014 May; 207():81-92. PubMed ID: 24200086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
    Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D
    ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases.
    Wu Y; Ma B; Liu C; Li D; Sui G
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of amyloidogenic protein oligomerization in neurodegenerative disease.
    Lotz GP; Legleiter J
    J Mol Med (Berl); 2013 Jun; 91(6):653-64. PubMed ID: 23529761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting protein aggregation with nanomaterials: The underlying mechanisms and impact factors.
    Wang S; Zheng J; Ma L; Petersen RB; Xu L; Huang K
    Biochim Biophys Acta Gen Subj; 2022 Feb; 1866(2):130061. PubMed ID: 34822925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.
    Ge X; Yang Y; Sun Y; Cao W; Ding F
    ACS Chem Neurosci; 2018 May; 9(5):967-975. PubMed ID: 29378116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unifying framework for amyloid-mediated membrane damage: The lipid-chaperone hypothesis.
    Tempra C; Scollo F; Pannuzzo M; Lolicato F; La Rosa C
    Biochim Biophys Acta Proteins Proteom; 2022 Apr; 1870(4):140767. PubMed ID: 35144022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.
    Gong H; Yang X; Zhao Y; Petersen RB; Liu X; Liu Y; Huang K
    Curr Protein Pept Sci; 2015; 16(2):135-46. PubMed ID: 25692950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the Effects of Copper Ions in the Aggregation of Amyloidogenic Proteins.
    Oliveri V
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of intra and inter-molecular disulfide bonds in modulating amyloidogenesis: A review.
    Mitra A; Sarkar N
    Arch Biochem Biophys; 2022 Feb; 716():109113. PubMed ID: 34958750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.